Experimental pulmonary infection and colonization of Haemophilus influenzae in emphysematous hamsters

Pulmonary Pharmacology and Therapeutics

Volumn 23, Issue 4, 2010, Pages 292-299

  Wang, Dong ^a,b   Wang, Ying ^b   Liu, You ning ^b  

^a AIR FORCE GENERAL HOSPITAL   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Disease models, animal; Haemophilus influenzae; Moxifloxacin; Pulmonary disease, chronic obstructive; Pulmonary emphysema

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; MOXIFLOXACIN; PANCREATIC ELASTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL SURVIVAL; BACTERIUM ISOLATION; CELL COUNT; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; DRUG EFFICACY; EXPERIMENTAL INFECTION; HAEMOPHILUS INFLUENZAE; HISTOPATHOLOGY; HOMOGENATE; INFLAMMATION; INOCULATION; LUNG EMPHYSEMA; LUNG HEMORRHAGE; LUNG INFECTION; LUNG LAVAGE; LUNG PARENCHYMA; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROVOCATION TEST; SYRIAN HAMSTER; TREATMENT DURATION;

ANIMALS; ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; BRONCHOALVEOLAR LAVAGE FLUID; COLONY COUNT, MICROBIAL; CRICETINAE; DISEASE MODELS, ANIMAL; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; INFLAMMATION; LUNG; MALE; NEUTROPHILS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; QUINOLINES; SURVIVAL RATE; SWINE; TIME FACTORS;

EID: 77953119717     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2010.02.006     Document Type: Article

References (31)

1. Wedzicha J.A., and Donaldson G.C. Exacerbations of chronic obstructive pulmonary disease. Respir Care 48 12 (2003) 1204-1213
2. Wedzicha J.A., and Seemungal T.A. COPD exacerbations: defining their cause and prevention. Lancet 370 9589 (2007) 786-796
3. Hayes Jr. D., and Meyer K.C. Acute exacerbations of chronic bronchitis in elderly patients: pathogenesis, diagnosis and management. Drugs Aging 24 7 (2007) 555-572
4. Sethi S. Bacteria in exacerbations of chronic obstructive pulmonary disease: phenomenon or epiphenomenon?. Proc Am Thorac Soc 1 2 (2004) 109-114
5. Veeramachaneni S.B., and Sethi S. Pathogenesis of bacterial exacerbations of COPD. COPD 3 2 (2006) 109-115
6. Anzueto A., Sethi S., and Martinez F.J. Exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 4 7 (2007) 554-564
7. Patel A., and Wilson R. Newer fluoroquinolones in the treatment of acute exacerbations of COPD. Int J Chron Obstruct Pulmon Dis 1 3 (2006) 243-250
8. Sethi S., Evans N., Grant B.J., and Murphy T.F. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 347 (2002) 465-471
9. Sapey E., and Stockley R.A. COPD exacerbations. 2: aetiology. Thorax 61 3 (2006) 250-258
10. Sethi S., Wrona C., Grant B.J., and Murphy T.F. Strain-specific immune response to Haemophilus influenzae in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 169 (2004) 448-453
11. Sethi S., and Murphy T.F. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 359 22 (2008) 2355-2365
12. Murphy T.F. The role of bacteria in airway inflammation in exacerbations of chronic obstructive pulmonary disease. Curr Opin Infect Dis 19 3 (2006) 225-230
13. Miyazaki S., Fujikawa T., Matsumoto T., Tateda K., and Yamaguchi K. Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice. J Antimicrob Chemother 48 (2001) 425-430
14. Yukie S., Masahiro E., Masahiko N., Kimiko U., Satoshi O., and Hidenori M. Comparative efficacies of different antibiotic treatments to eradicate nontypeable Haemophilus influenzae infection. BMC Infect Dis 8 (2008) 15
15. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Seventeenth informational supplement. M100-S17 (2007), National Committee for Clinical Laboratory Standards, Wayne, Pa
16. Hayes J.A., Korthy A., and Snider G.L. The pathophysiology of elastase-induced panacinar emphysema in hamster. J Pathol 117 1 (1975) 1-14
17. Raub J.A., Mercer R.R., Miller F.J., Graham J.A., and O'Neil J.J. Dose response of elastase-induced emphysema in hamsters. Am Rev Respir Dis 125 4 (1982) 432-435
18. Hayatdavoudi G., Crapo J.D., Miller F.J., and O'Neil J.J. Factors determining degree of inflation in intratracheally fixed rat lungs. J Appl Physiol 48 2 (1980) 389-393
19. Dunnill M.S. Quantitative methods in the study of pathology. Thorax 17 (1962) 320
20. Thurlbeck W.M. Measurement of pulmonary emphysema. Am Rev Respir Dis 95 5 (1967) 752-764
21. Slater M. A rat model of prolonged pulmonary Infection due to non-typable Haemophilus influenzae. Am Rev Respir Dis 142 (1990) 1429-1435
22. Sjobring U., and Taylor J.D. Models of exacerbations in asthma and COPD: a human rhinovirus model of chronic obstructive pulmonary disease exacerbations. Contrib Microbiol 14 (2007) 101-112
23. Sjobring U., and Taylor J.D. Models of exacerbations in asthma and COPD: animal models of chronic obstructive pulmonary disease exacerbations. Contrib Microbiol 14 (2007) 126-141
24. Patrick M., and Sebastian L.J. Mechanisms and experimental models of chronic obstructive pulmonary disease exacerbations. Proc Am Thorac Soc 2 (2005) 361-366
25. O'Reilly T. Relevance of animal models for chronic bacterial airway infections in humans. Am J Respir Crit Care Med 151 (1995) 2101-2108
26. Miravitlles M., and Anzueto A. Moxifloxacin: a respiratory fluoroquinolone. Expert Opin Pharmacother 9 10 (2008) 1755-1772
27. Aaron S.D., Angel J.B., Lunau M., Wright K., Fex C., Le Saux N., et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163 (2001) 349-355
28. Bresser P., Out T.A., van Alphen L., Jansen H.M., and Lutter R. Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic Haemophilus influenzae airway infection: comparison with noninfected patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162 (2000) 947-952
29. Sethi S., Muscarella K., Evans N., Klingman K.L., Grant B.J., and Murphy T.F. Airway inflammation and etiology of acute exacerbations of chronic bronchitis. Chest 118 (2000) 1557-1565
30. Keatings V.M., Collins P.D., Scott D.M., and Barnes P.J. Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 153 (1996) 530-534
31. Hill A.T., Campbell E.J., Bayley D.L., Hill S.L., and Stockley R.A. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with β1-antitrypsin deficiency (PiZ). Am J Respir Crit Care Med 160 (1999) 1968-1975